COYA (Coya Therapeutics) OCF Margin %: -3,022.95% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

COYA Coya Therapeutics Inc COYA
49 GF Score
Price $4.39
GF Value $6.54
Valuation Significantly Undervalued
View Full Analysis

What is Coya Therapeutics OCF Margin %?

Coya Therapeutics COYA -3.10% 49 OCF Margin % is -3,022.95% as of Jun. 2026. GuruFocus rates COYA with a GF Score™ of 49/100 and a GF Value™ of $6.54 (Significantly Undervalued). Among 961 Biotechnology companies, Coya Therapeutics ranks worse than 62.23% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Coya Therapeutics's Cash Flow from Operations for the three months ended in Jun. 2026 was $-7.38 Mil. Coya Therapeutics's Revenue for the three months ended in Jun. 2026 was $0.24 Mil. Therefore, Coya Therapeutics's OCF Margin % for the quarter that ended in Jun. 2026 was -3,022.95%.

As of today, Coya Therapeutics's current OCF Yield % is -15.27%.

The historical rank and industry rank for Coya Therapeutics's OCF Margin % or its related term are showing as below:

COYA' s OCF Margin % Range Over the Past 10 Years
Min: -289.5   Med: -186.42   Max: -135.15
Current: -196.07

During the past 6 years, the highest OCF Margin % of Coya Therapeutics was -135.15%. The lowest was -289.50%. And the median was -186.42%.

COYA's OCF Margin % is ranked worse than
62.23% of 961 companies
in the Biotechnology industry
Industry Median: -67.62 vs COYA: -196.07

Coya Therapeutics OCF Margin % Related Terms

Coya Therapeutics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Coya Therapeutics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coya Therapeutics OCF Margin % Chart

Coya Therapeutics Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial 0.00 0.00 -186.42 -289.50 -135.15

Coya Therapeutics Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3,520.12 -31.73 -25.43 -2,473.71 -3,022.95

COYA vs ONCY, GUTS, SEER: OCF Margin % Comparison

For the Biotechnology subindustry, Coya Therapeutics's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Coya Therapeutics OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Coya Therapeutics's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Coya Therapeutics's OCF Margin % falls into.


COYA
49GF Score
Coya Therapeutics Inc COYA
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Coya Therapeutics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Coya Therapeutics's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-10.739/7.946
=-135.15 %

Coya Therapeutics's OCF Margin for the quarter that ended in Jun. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Jun. 2026 )/Revenue (Q: Jun. 2026 )
=-7.376/0.244
=-3,022.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -3,022.95% mean?
Coya Therapeutics (COYA) has a OCF Margin % of -3,022.95% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Coya Therapeutics and its competitors. According to the industry distribution chart, Coya Therapeutics ranks #598 out of 961 companies in the Biotechnology industry, placing it in the top 62.2%.
Is Coya Therapeutics' OCF Margin % too high?
Coya Therapeutics' current OCF Margin % is -3,022.95%. Based on the distribution chart, Coya Therapeutics ranks #598 out of 961 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Coya Therapeutics has a GF Score™ of 49/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Coya Therapeutics' OCF Margin % compare to ONCY and GUTS?
According to the Biotechnology industry distribution chart, Coya Therapeutics ranks #598 out of 961 companies for OCF Margin %. This places Coya Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Coya Therapeutics and its competitors. Coya Therapeutics's current OCF Margin % is -3,022.95%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coya Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, Coya Therapeutics (COYA) is currently considered Significantly Undervalued. The stock's GF Value™ is $6.54, compared to a current price of $4.39 — trading 32.9% below its estimated fair value. The current OCF Margin % is -3,022.95%. Coya Therapeutics' overall GF Score™ is 49/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Coya Therapeutics (COYA), the current OCF Margin % is -3,022.95% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Coya Therapeutics (COYA) Overvalued in 2026?

Based on GuruFocus' analysis, Coya Therapeutics stock appears to be undervalued. The current stock price of $4.39 is trading 32.9% below its estimated GF Value™ of $6.54. GuruFocus considers Coya Therapeutics to be Significantly Undervalued.

Key valuation signals for COYA:

  • OCF Margin %: -3,022.95%
  • GF Value™: $6.54 vs. price of $4.39 (32.9% below fair value)
  • GF Score™: 49/100

No single metric tells the full story. See the COYA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Coya Therapeutics Business Description

Address 5850 San Felipe Street, Suite 500, Houston, TX, USA, 77057
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.
49GF Score

Get the complete analysis for COYA

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.39
Price
$6.54
GF Value